How do I find out if I qualify for a breast lobular carcinoma in situ study in Kansas?

Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.

Do I have to live in Kansas to take part?

Not necessarily. These studies have a site in Kansas, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.

Does it cost anything to join a breast lobular carcinoma in situ trial?

Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.

Clinical trials · Kansas

Breast Lobular Carcinoma In Situ clinical trials in Kansas

We’re tracking 4 recruiting breast lobular carcinoma in situ studies with a site in Kansas — including Phase 2 and Phase 3 studies, each written for real people, not researchers.

Recruiting studies in Kansas

NCT06184750RecruitingPhase 2
Finding the best tamoxifen dose to lower breast cancer risk
This trial tests different doses of tamoxifen to find the best one for lowering breast cancer risk in premenopausal women. It aims to see if a lower dose works as well as the standard dose with fewer side effects.
Kansas City, KansasAges 18–55
NCT06195306RecruitingPhase 2
Low dose tamoxifen and omega-3 for breast cancer prevention
This study tests whether low-dose tamoxifen (a breast cancer prevention drug) or omega-3 supplements can lower breast cancer risk in postmenopausal women who are overweight and have a higher chance of getting the disease. The study lasts about 6 months and involves blood draws and a breast fluid test to see how the treatment affects breast cells.
Kansas City, KansasAges 45–74
NCT05941520RecruitingPhase 2
Acolbifene vs low-dose tamoxifen to prevent breast cancer
This Phase 2 trial compares acolbifene and low-dose tamoxifen to see which better lowers breast cancer risk in premenopausal women at high risk. You would be followed with health visits, blood tests, and a breast tissue sampling procedure.
Kansas City, KansasAges 35 years+
NCT05812807RecruitingPhase 3
Pembrolizumab versus monitoring after triple-negative breast cancer response
This trial checks whether giving pembrolizumab (an immunotherapy) after surgery helps people with triple-negative breast cancer reduce the chance of the cancer coming back, compared with close monitoring only. It’s for patients who had no remaining invasive cancer after neoadjuvant chemotherapy plus pembrolizumab.
Chanute, KansasAges 18 years+

Where these studies are running in Kansas

Institutions with a site for the recruiting breast lobular carcinoma in situ studies listed above.

University of Kansas Medical Center · 4 studies
Ascension Via Christi Hospitals Wichita
Cancer Center of Kansas - Chanute
Cancer Center of Kansas - Dodge City
Cancer Center of Kansas - El Dorado
Cancer Center of Kansas - McPherson
Cancer Center of Kansas - Newton
Cancer Center of Kansas - Parsons

What taking part in a breast lobular carcinoma in situ study involves

A screening visit first

Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.

Care at a nearby site

Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.

You stay in control

Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.

The team decides eligibility

Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.

Breast Lobular Carcinoma In Situ trials in other states

Ohio

Common questions

Are there breast lobular carcinoma in situ clinical trials in Kansas?: Yes. We're currently tracking 4 recruiting breast lobular carcinoma in situ studies with a site in Kansas, each rewritten in plain language so you can see what it's testing and who it's for.
How do I find out if I qualify for a breast lobular carcinoma in situ study in Kansas?: Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
Do I have to live in Kansas to take part?: Not necessarily. These studies have a site in Kansas, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
Does it cost anything to join a breast lobular carcinoma in situ trial?: Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.

Not the right time?

New breast lobular carcinoma in situ studies open in Kansas regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.

Get told when a study that fits you opens

Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.